A $4,000 hearing aid sale on day one is not $4,000 of revenue. It is a liability until the trial period closes.
Audiology is a clinical practice grafted to a hearing aid retail business, and the retail side has a feature that almost no other healthcare practice deals with: a federally and state-mandated trial period during which the patient can return the device for a full refund. Federal rules and most state regulations require a trial of at least 30 days. Many practices offer 45 or 60 days as a competitive feature.
That trial period is the most-mishandled element in audiology bookkeeping. Generic bookkeepers book the patient's payment as cash income on the day of dispense. When the patient returns the aids during the trial (industry-wide return rates run 5 to 15 percent depending on practice and demographic), the bookkeeper then has to claw the revenue back, often awkwardly, often after a tax period has closed. The practice ends up paying tax on revenue it never actually earned.
Here is how to handle it correctly.
Why the trial-period payment is a liability, not revenue
The accounting principle is straightforward. Revenue should be recognized when it is earned. A patient who pays $4,000 on the day of dispense has not yet given the practice the right to keep that money. They retain the option to return the device and recover the full payment for the duration of the trial period. The transaction is, economically, a deposit against a possible future sale.
The right way to book it is as a credit to a "Hearing aid trial deposits" liability account on the balance sheet on the day of dispense. When the trial closes (no return received in the contractual window), the liability is reclassified to revenue. When a return happens during the trial, the liability is cleared back to cash without ever touching revenue.
The cleanliness of this approach is notable. The P&L only ever sees revenue that the practice actually earned. Returns never produce a revenue reversal. The balance sheet always shows the dollar value of trials currently in flight, which is genuinely useful information about the practice's near-term cash position.
The chart of accounts
The minimum useful setup for a single-clinician audiology practice looks like this.
Liability accounts. "Hearing aid trial deposits" as a current liability. Most practices benefit from a sub-account per major manufacturer (Phonak, Oticon, Widex, Signia, Starkey) because the deposit-to-revenue conversion timing varies slightly by manufacturer return policy.
Revenue accounts. "Hearing aid revenue" with sub-accounts for the major manufacturers, separate from "Clinical service revenue" (exam fees, real-ear measurements, programming sessions, follow-ups). Hearing aid revenue should be reported separately from clinical service revenue because the COGS profile, the margin profile, and the QBI implications are completely different.
COGS account. "Hearing aid COGS" booked to the period the deposit converts to revenue, not the period the device was ordered or paid for. Most practices track inventory by serial number once volumes warrant it, but smaller practices can use period-by-period COGS just fine.
Manufacturer rebate income. Tracked separately from hearing aid revenue. Volume rebates, co-op marketing dollars, and quarterly bonuses from manufacturers are real income with real tax implications, and they should be visible as their own line in the practice's books.
What happens when a patient returns aids during the trial
The return process is mechanically simple under deferred revenue treatment. The liability is cleared, the patient's payment is refunded, and any restocking fee retained by the practice (typical in most states; check your state's rules) is recognized as service revenue. No revenue reversal hits your monthly P&L.
This matters for two reasons. First, your monthly P&L stays clean and tells an accurate story of practice performance. Second, when you eventually face an IRS or state tax authority looking at your books, the records show what actually happened (a deposit that was returned) rather than a confusing pattern of revenue posted then reversed.
Rebates and co-op marketing dollars are their own beast
Manufacturer rebates are recognized when they are earned, not when the rebate check arrives. For volume-tier rebates, that often means accruing rebate income across the period the qualifying purchases were made. For co-op marketing dollars (manufacturer reimbursement for advertising spend), the income is recognized when the marketing activity happens, with the rebate offsetting the advertising expense.
Most generic bookkeepers ignore this entirely and book rebates only when checks arrive, which compresses six months of rebate income into one quarter and distorts P&L comparability. For practices doing serious volume with one or two manufacturers, the accrual approach is worth the extra complexity.
Tax implications
The deferred revenue treatment has tangible tax-planning consequences for an audiology practice.
Cleaner cash basis vs accrual basis decisions. Some audiology practices outgrow cash-basis tax accounting once trial-period balances become significant. Knowing the exact trial liability at year end is the key data point for that decision, and we surface it during onboarding.
Section 199A and QBI optimization. Audiology is generally treated as a specified service trade under Section 199A, but the analysis can get nuanced for practices with significant retail revenue. Separating clinical revenue from hearing aid revenue in the books is a prerequisite for that analysis.
Inventory accounting. Hearing aids and accessory inventory may need to be tracked under IRC Section 471 rules depending on revenue scale. Most small audiology practices fall under the small business inventory exception, but practices over $25M in average gross receipts (almost no audiology practices are anywhere near this) face different rules. Knowing where your practice sits matters.
Reasonable compensation benchmarking. S-Corp reasonable comp for audiologists benchmarks against BLS wage data, but practices with significant retail revenue have a different comp profile than pure clinical practices. The split in the books makes the analysis defensible.
Key takeaways.
- Hearing aid trial-period payments are deposits, not revenue. Book them as a balance sheet liability until the trial closes.
- Returns clear the liability without ever touching revenue. The P&L stays clean and IRS-ready.
- Manufacturer rebates and co-op marketing dollars are real income that should be recognized when earned, not when checks arrive.
- The clean split of clinical revenue, hearing aid revenue, and rebate income is the foundation for all serious tax planning in audiology.
Common questions
What if I am cash-basis for tax purposes?
Cash-basis tax accounting still works fine. The deferred revenue treatment is for your management books and your monthly P&L. At year end, we reconcile to cash basis for the tax return while your management books continue to show economic reality.
Do I need to track inventory by serial number?
For practices with significant volume and multiple manufacturers, yes, because manufacturer-specific volume tracking and warranty management both require it. For solo practices ordering per patient, period-based COGS is fine. We can advise on the threshold during onboarding.
How do I handle hearing aids that are insurance-paid?
Insurance-paid devices have a different revenue recognition pattern than self-pay devices because there is no patient-side trial-period option in most cases (the patient cannot get insurance to refund the device). We treat them as standard insurance revenue with EOB reconciliation, separate from self-pay devices.
What about pediatric SLP practices contracted to school districts?
School and early-intervention contracts have their own quirks (60- to 120-day payment cycles, contract-receivables aging, sometimes multi-quarter accruals). We track them as contract receivables and reconcile against payment cycles. Different setup from audiology retail, same principle of matching revenue to delivered services.
How long does it take to set up deferred revenue tracking on existing books?
For most audiology practices, two to four weeks of restructuring as part of onboarding. We capture in-flight trial deposits at the start, set up the new chart of accounts, and run parallel tracking for one month so you can see the difference before going live.
Keep reading
- Bookkeeping for Audiologists & SLPs
- Sales Tax on Herbal Medicine — another retail-with-services practice that gets sales tax wrong
- Cash-Pay vs Insurance PT Books — same dual-stream economics, different vertical
- What Is Reasonable Compensation for S-Corp Owners?
- Why We Focus on Private Practices
See if we are the right fit
If you run an audiology practice and your books treat hearing aid trials the same as exam revenue, book a free 30-minute consult. Bring a recent month's hearing aid sales and any return data you have. We will show you what deferred-revenue treatment would look like on your numbers and whether we are the right fit.